Apotex Inc. (“Apotex”) brought an action for impeachment seeking a declaration that Lundbeck’s Canadian Patent No. 1,339,452 (the “’452 Patent”) is invalid.
March 18, 2013
Teva Canada Limited (“Teva”) and Apotex Inc. (“Apotex”) wish to sell generic versions of GLEEVEC®, a highly effective drug for the treatment of chronic myeloid...
February 26, 2013
This was an appeal from a decision of the Federal Court granting Celgene Inc.’s (“Celgene”) application for judicial review and quashing a decision of the...
February 21, 2013
Eli Lilly Canada Inc. (“Lilly”) brought an application under the Patented Medicines (Notice of Compliance) Regulations (the “NOC Regulations”) for an Order...
January 28, 2013
This was an appeal from the decision of the Federal Court which had dismissed Takeda’s application for judicial review of the Minister’s refusal to list Takeda’s...
January 23, 2013
This is the first proceeding under the Patented Medicine (Notice of Compliance Regulations) (“NOC Regulations”) brought by Apotex Inc.
January 22, 2013
The Quebec government recently announced, as part of its budget, the intended abolishment of the rule known as “BAP-15.”
January 11, 2013
Charles Walker is Head of IP Disputes, United States. Charles tries and wins IP cases. As lead counsel, he won jury verdicts of $5.1 million and ...
December 07, 2012
Social media is starting to affect every company, and legal issues arising from social media are similarly increasing. In this breakfast meeting,...
December 04, 2012
Die ICANN mit Sitz in den USA hat im letzten Jahr im Rahmen ihres "New gTLD Program" entschieden, neue generische Domain-Endungen einzuführen.
November 22, 2012
Try searching our global site instead